What counter-ion should I expect on a QYB semaglutide lot?

What I am working with: QYB · semaglutide.

I have the document in front of me and I can read the numbers. What I cannot do is interpret them.

I am reasonably comfortable with statistics and completely uncomfortable with chromatography, or vice versa.

What is the correct interpretation, and what is the common misreading?

Answer first: the counter-ion is part of the mass you paid for and none of the peptide you wanted, and it can run to several per cent or more.

Peptides purified by reverse-phase chromatography with a trifluoroacetic acid mobile phase are isolated as trifluoroacetate salts. The trifluoroacetate content depends on the number of basic residues and can run from a few per cent to well over ten by mass on a heavily basic sequence.

Trifluoroacetate has documented biological effects at higher concentrations in cell culture, which is the technical reason acetate exchange exists rather than a marketing one.

Count the basic residues and you can estimate the counter-ion load.

Answering this needs the purification method, since a trifluoroacetic acid mobile phase leaves trifluoroacetate unless a deliberate exchange was performed.

Net peptide content — the fraction of gross mass that is the peptide itself — is the figure that folds water and counter-ion together and is what you should ask for if you ask for anything.

It helps to be literal here: a supplier who reports both water and counter-ion has given you everything needed to reconcile the vial, and on this site that is a very short list.

Trifluoroacetate unless a deliberate exchange was done. Ask which.

Mechanically, acetate is generally preferred to trifluoroacetate for biological work, which is why the exchange is done at all.

Acetate salts are produced by a deliberate ion exchange after purification. The exchange costs a processing step and is the reason acetate-form material is more expensive.

The number of basic residues drives counter-ion load, because each protonated basic site pairs with one counter-ion. A sequence with several lysines and arginines carries proportionally more.

Peptides from reverse-phase purification with trifluoroacetic acid mobile phases are isolated as trifluoroacetate salts, which is standard synthesis practice.

Absence of a counter-ion figure is an absent measurement rather than a low one.

Ask for net peptide content. It folds water and counter-ion into one usable number.

The honest answer is that most certificates are silent on it and that the number can be large enough to matter.

Quantification differs by ion: trifluoroacetate by ion chromatography or by fluorine nuclear magnetic resonance, acetate by ion chromatography or by capillary electrophoresis. Neither shows up on a UV chromatogram.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Purity says nothing about counter-ion. They are unrelated measurements.

The relevant arithmetic is that gross mass equals peptide plus counter-ion plus water, and the certificate usually reports only the first indirectly.

Worked reconciliation: a 10 mg vial at four per cent water and eight per cent trifluoroacetate contains 10.0 × 0.88 = 8.8 mg of peptide, a twelve per cent shortfall against label with a perfectly clean purity figure.

Ion chromatography and fluorine NMR are the accepted quantitative methods for trifluoroacetate, and neither is a chromatographic purity method.

The caveat is that a purity figure is completely blind to counter-ion content, and the two are routinely conflated.

Water plus counter-ion is why gross mass and peptide mass differ.

edited 6 Dec 2024 by Dr_Nadia_Farsi — corrected a unit error in the worked example